文献速递前列腺癌

NCCN有利中危前列腺癌是否适合主动监测

National Comprehensive Cancer Network® Favorable Intermediate Risk Prostate Cancer-Is Active Surveillance Appropriate?
PubMed 文献 · J Urol · 2017-12-26

该研究比较了符合NCCN主动监测标准的有利中危前列腺癌患者与极低危、低危及不利中危患者根治性前列腺切除术后的病理和生化结局。有利中危患者不良病理发现率显著高于低危(27.4% vs 14.8%)且显著低于不利中危(27.4% vs 48.5%),生化复发时间各组间有显著差异。结论认为有利中危是独立群体,选择主动监测及监测中需谨慎。

要点

  • 有利中危患者不良病理率27.4%,高于低危14.8%,低于不利中危48.5%,各p<0.001。
  • 生化复发时间在风险组间差异显著(p<0.001)。
  • 有利中危为独立群体,主动监测选择和监测需谨慎。

核心结论

  • 有利中危前列腺癌患者是区别于低危的独立群体,选择主动监测及监测中需谨慎。

研究设计与样本

  • 基于机构审查委员会批准的前列腺癌数据库,纳入2014年1月1日至2015年12月31日接受根治性前列腺切除术的患者,按NCCN标准分为极低危、低危、有利中危和不利中危。

主要发现

  • 共3686例接受根治性前列腺切除术,其中低危1454例、有利中危250例、不利中危1362例。
  • 有利中危不良病理发现率27.4%,显著高于低危14.8%,显著低于不利中危48.5%,各p<0.001。
  • 生化复发时间在风险组间差异显著(p<0.001)。

关键数值与推荐

  • 有利中危标准:主要模式分级3且阳性穿刺针数<50%,并具有1个中危因素(T2b/c、Grade Group 2或PSA 10-20 ng/ml)。
  • 极低危标准:T1c、Grade Group 1、12针中≤3针阳性、≤50%针体积、PSA密度<0.15 ng/ml。
  • 低危标准:T1-T2a、Grade Group 1、PSA<10 ng/ml。
  • 不利中危:中危但不满足有利中危标准者。
  • 不良病理包括Gleason评分Grade Group 3-5、非器官局限疾病或淋巴结受累。

临床怎么用

  • 对有利中危患者选择主动监测及监测期间需谨慎。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We compared pathological and biochemical outcomes after radical prostatectomy in patients at favorable intermediate risk who fulfilled current NCCN® (National Comprehensive Cancer Network®) Guidelines® for active surveillance criteria to outcomes in patients who met more traditional criteria for active surveillance. MATERIALS AND METHODS: We queried our institutional review board approved prostate cancer database for patients who met NCCN criteria for very low risk (T1c, Grade Group 1, 3 or fewer of 12 cores, 50% or less core volume and prostate specific antigen density less than 0.15 ng/ml), low risk (T1-T2a, Grade Group 1 and prostate specific antigen less than 10 ng/ml) or favorable intermediate risk (major pattern grade 3 and less than 50% positive biopsy cores) and who had 1 intermediate risk factor, including T2b/c, Grade Group 2 or prostate specific antigen 10 to 20 ng/ml. Men at intermediate risk who did not meet favorable criteria were labeled as being at unfavorable intermediate risk. Patients at favorable intermediate risk were compared to those at very low and low risk, and those at unfavorable intermediate risk to identify differences in rates of adverse pathological findings at radical prostatectomy, including Gleason score Grade Group 3-5, nonorgan confined disease or nodal involvement. Time to biochemical recurrence was compared among the groups using Cox regression. RESULTS: A total of 3,686 patients underwent radical prostatectomy between January 1, 2014 and December 31, 2015. Of these men 1,454, 250 and 1,362 fulfilled the criteria for low, favorable intermediate and unfavorable intermediate risk, respectively. The rate of adverse pathological findings in favorable intermediate risk cases was significantly higher than in low risk cases and significantly lower than in unfavorable intermediate risk cases (27.4% vs 14.8% and 48.5%, respectively, each p <0.001). Time to biochemical recurrence differed significantly among the risk groups (p <0.001). CONCLUSIONS: Relative to men at low risk those at favorable intermediate risk represent a distinct group. Care should be taken when selecting these patients for active surveillance and monitoring them once they are in an active surveillance program.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Aghazadeh MA, Frankel J, Belanger M, et al. National Comprehensive Cancer Network® Favorable Intermediate Risk Prostate Cancer-Is Active Surveillance Appropriate? J Urol. 2017. PMID: 29288120. doi:10.1016/j.juro.2017.12.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。